These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 7551844)

  • 21. The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density.
    Bangma CH; Kranse R; Blijenberg BG; Schröder FH
    Urology; 1995 Dec; 46(6):779-84. PubMed ID: 7502415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The risks of prostate cancer detection by transrectal ultrasound guide biopsy in Thai men with abnormal prostatic-specific antigen or abnormal digital rectal examination.
    Leewansangtong S; Tantiwong A; Ratanarapee S; Nualyong C; Soontrapa S
    J Med Assoc Thai; 2000 Dec; 83(12):1519-24. PubMed ID: 11253893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations.
    Gohji K; Nomi M; Egawa S; Morisue K; Takenaka A; Okamoto M; Ohori M; Fujii A
    Cancer; 1997 May; 79(10):1969-76. PubMed ID: 9149025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL.
    Törnblom M; Norming U; Adolfsson J; Becker C; Abrahamsson PA; Lilja H; Gustafsson O
    Urology; 1999 May; 53(5):945-50. PubMed ID: 10223488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Yield of ultrasonography-guided transrectal biopsy in the diagnosis of carcinoma of the prostate].
    Fernández González I; Ruiz Rubio JL; Llorente Abarca C; Aramburu González JA; Montes Díaz MJ; Herrero Payo A; Sánchez Sánchez E; Berenguer Sánchez A
    Arch Esp Urol; 1995; 48(6):587-94. PubMed ID: 7544968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia.
    Roehrborn CG; Boyle P; Gould AL; Waldstreicher J
    Urology; 1999 Mar; 53(3):581-9. PubMed ID: 10096388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for prostatic carcinoma with prostate specific antigen.
    Brawer MK; Chetner MP; Beatie J; Buchner DM; Vessella RL; Lange PH
    J Urol; 1992 Mar; 147(3 Pt 2):841-5. PubMed ID: 1371559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percent free PSA as an additional measure in a prostate cancer screen.
    Miele ME
    Clin Lab Sci; 2001; 14(2):102-7. PubMed ID: 15625982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Digital rectal examination as a prostate cancer-screening method in a country with a low incidence of prostate cancer.
    Shim HB; Lee SE; Park HK; Ku JH
    Prostate Cancer Prostatic Dis; 2007; 10(3):250-5. PubMed ID: 17297501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Final results of a screening campaign for prostate cancer.
    Martín E; Luján M; Sánchez E; Herrero A; Páez A; Berenguer A
    Eur Urol; 1999 Jan; 35(1):26-31. PubMed ID: 9933791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-related reference levels of serum prostate-specific antigen among Taiwanese men without clinical evidence of prostate cancer.
    Lin KJ; Pang ST; Chang YH; Wu CT; Chuang KL; Chuang HC; Chuang CK
    Chang Gung Med J; 2010; 33(2):182-7. PubMed ID: 20438671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extended use of Prostate Health Index and percentage of [-2]pro-prostate-specific antigen in Chinese men with prostate specific antigen 10-20 ng/mL and normal digital rectal examination.
    Chiu PK; Teoh JY; Lee WM; Yee CH; Chan ES; Hou SM; Ng CF
    Investig Clin Urol; 2016 Sep; 57(5):336-42. PubMed ID: 27617315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective evaluation of prostate-specific antigen density and systematic biopsies for early detection of prostatic carcinoma.
    Bazinet M; Meshref AW; Trudel C; Aronson S; Péloquin F; Nachabe M; Bégin LR; Elhilali MM
    Urology; 1994 Jan; 43(1):44-51; discussion 51-2. PubMed ID: 7506853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population-based screening for prostate cancer by measuring total serum prostate-specific antigen in Iran.
    Hosseini SY; Moharramzadeh M; Ghadian AR; Hooshyar H; Lashay AR; Safarinejad MR
    Int J Urol; 2007 May; 14(5):406-11. PubMed ID: 17511722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of age, benign prostatic hyperplasia, and cancer on prostate-specific antigen level.
    Punglia RS; D'Amico AV; Catalona WJ; Roehl KA; Kuntz KM
    Cancer; 2006 Apr; 106(7):1507-13. PubMed ID: 16518812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relative contribution of digital rectal examination and transrectal ultrasonography in interpreting serum prostate-specific antigen values for screening prostate cancer in Arab men.
    Sheikh M; Sinan T; Kehinde EO; Hussein AY; Anim JT; Al-Hunayan AA
    Ann Saudi Med; 2007; 27(2):73-8. PubMed ID: 17356323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical utility of available diagnostic tests in prostatic carcinoma. Results of 500 biopsies. II. Rectal palpation, PSA, and transrectal echography].
    Rodríguez Rodríguez R; Mayayo Dehesa T; Galbis Sanjuan F; Jiménez Cidre M; Burgos Revilla FJ; Gómez dos Santos V; García González R
    Arch Esp Urol; 1997 May; 50(4):339-45. PubMed ID: 9313042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostate cancer screening in Tyrol, Austria: experience and results.
    Horninger W; Reissigl A; Rogatsch H; Volgger H; Studen M; Klocker H; Bartsch G
    Eur Urol; 1999; 35(5-6):523-38. PubMed ID: 10325519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of prostate-specific antigen and prostate-specific antigen density with outcome of prostate biopsy.
    Bare R; Hart L; McCullough DL
    Urology; 1994 Feb; 43(2):191-6. PubMed ID: 7509526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of age-specific reference range of prostate-specific antigen for Japanese men older than 60 years in mass screening for prostate cancer.
    Ito K; Yamamoto T; Kubota Y; Suzuki K; Fukabori Y; Kurokawa K; Yamanaka H
    Urology; 2000 Aug; 56(2):278-82. PubMed ID: 10925094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.